TransMedics Group, Inc. reported an insider ownership update involving Nicholas Corcoran, the company’s Senior Vice President of Supply Chain and Operations. The reported event date was July 10, 2026, and the filing was submitted on July 14, 2026. The filing concerns TransMedics common stock and equity-based compensation holdings. Corcoran’s reported beneficial ownership includes 11,727 restricted stock units, or RSUs. Each RSU represents a contingent right to receive one share of TransMedics common stock, meaning the units would convert into shares subject to the applicable vesting and settlement terms. The filing also references a stock option award. According to the explanatory note, the option vests monthly at a rate of 2.0833% of the total shares subject to the option, beginning after April 10, 2026, and is scheduled to become fully vested on April 10, 2030, provided Corcoran continues to provide service to the company. This vesting schedule is consistent with a four-year monthly vesting structure. No open-market purchase or sale price is included in the provided filing text, and no specific transaction code, exercise price, or total number of option shares is shown. Based on the available details, the report appears to document an insider equity ownership position and related vesting terms rather than a disclosed market sale or purchase of TransMedics shares.